Insider Transactions in Q4 2025 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Stuart Holden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Nov 26
2025
|
Cynthia M Butitta Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Nov 26
2025
|
Daniel George Wildman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Nov 26
2025
|
Leana Wen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Nov 26
2025
|
James A. Robinson Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Nov 19
2025
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.71%
|
$250,000
$25.0 P/Share
|
|
Oct 08
2025
|
Chris Degnan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,203
-49.14%
|
$35,248
$16.85 P/Share
|
|
Oct 08
2025
|
Chris Degnan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,483
+50.0%
|
-
|